A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed

Trial end date:
2004-09-01

Target enrollment:

Participant gender:

To compare the efficacy and safety of tiotropium plus formoterol in comparison to salmeterol plus fluticasone in COPD patients.

Phase 4

Boehringer Ingelheim

Fluticasone
Formoterol Fumarate
Salmeterol Xinafoate
Tiotropium Bromide
Xhance